Ortivus AB (publ) (ORTI-B.ST)
SEK 1.48
(-6.62%)
SEK 1.48
(-6.62%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 30.84 Million SEK | -38.88% |
| 2022 | 48.72 Million SEK | 1.79% |
| 2021 | 47.86 Million SEK | 22.89% |
| 2020 | 38.95 Million SEK | 85.61% |
| 2019 | 20.98 Million SEK | -4.82% |
| 2018 | 22.04 Million SEK | -26.44% |
| 2017 | 29.97 Million SEK | -38.31% |
| 2016 | 48.58 Million SEK | -14.23% |
| 2015 | 56.64 Million SEK | 20.77% |
| 2014 | 46.9 Million SEK | 138.98% |
| 2013 | 19.62 Million SEK | -42.04% |
| 2012 | 33.86 Million SEK | 59.51% |
| 2011 | 21.22 Million SEK | -16.92% |
| 2010 | 25.55 Million SEK | -67.34% |
| 2009 | 78.24 Million SEK | 29.17% |
| 2008 | 60.57 Million SEK | -43.24% |
| 2007 | 106.72 Million SEK | -12.35% |
| 2006 | 121.75 Million SEK | 5.32% |
| 2005 | 115.59 Million SEK | -5.85% |
| 2004 | 122.77 Million SEK | -10.03% |
| 2003 | 136.46 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 9.11 Million SEK | 67.52% |
| 2024 Q2 | 5.29 Million SEK | -41.92% |
| 2023 Q3 | 4.84 Million SEK | -36.81% |
| 2023 Q1 | 13.47 Million SEK | 3.44% |
| 2023 FY | 29.78 Million SEK | -38.88% |
| 2023 Q4 | 5.44 Million SEK | 12.26% |
| 2023 Q2 | 7.67 Million SEK | -43.09% |
| 2022 Q1 | 11.63 Million SEK | -4.03% |
| 2022 Q2 | 15.14 Million SEK | 30.12% |
| 2022 Q3 | 8.91 Million SEK | -41.15% |
| 2022 Q4 | 13.03 Million SEK | 46.22% |
| 2022 FY | 48.72 Million SEK | 1.79% |
| 2021 Q3 | 12.4 Million SEK | 7.48% |
| 2021 Q2 | 11.54 Million SEK | -2.06% |
| 2021 FY | 47.86 Million SEK | 22.89% |
| 2021 Q1 | 11.78 Million SEK | 9.97% |
| 2021 Q4 | 12.12 Million SEK | -2.26% |
| 2020 Q3 | 7.83 Million SEK | -31.62% |
| 2020 Q1 | 8.95 Million SEK | 25.83% |
| 2020 Q2 | 11.45 Million SEK | 27.98% |
| 2020 FY | 38.95 Million SEK | 85.61% |
| 2020 Q4 | 10.71 Million SEK | 36.86% |
| 2019 Q4 | 7.11 Million SEK | 65.65% |
| 2019 FY | 20.98 Million SEK | -4.82% |
| 2019 Q3 | 4.29 Million SEK | -16.13% |
| 2019 Q2 | 5.12 Million SEK | 14.8% |
| 2019 Q1 | 4.46 Million SEK | -6.79% |
| 2018 FY | 22.04 Million SEK | -26.44% |
| 2018 Q1 | 5.48 Million SEK | -41.5% |
| 2018 Q2 | 4.88 Million SEK | -10.86% |
| 2018 Q3 | 6.89 Million SEK | 41.16% |
| 2018 Q4 | 4.78 Million SEK | -30.62% |
| 2017 Q4 | 9.36 Million SEK | 89.69% |
| 2017 Q3 | 4.93 Million SEK | -41.24% |
| 2017 Q2 | 8.4 Million SEK | 15.8% |
| 2017 Q1 | 7.25 Million SEK | -52.83% |
| 2017 FY | 29.97 Million SEK | -38.31% |
| 2016 Q1 | 9.91 Million SEK | -50.24% |
| 2016 FY | 48.58 Million SEK | -14.23% |
| 2016 Q4 | 15.38 Million SEK | 17.53% |
| 2016 Q3 | 13.09 Million SEK | 28.48% |
| 2016 Q2 | 10.19 Million SEK | 2.81% |
| 2015 Q2 | 14.45 Million SEK | 4.02% |
| 2015 Q3 | 8.37 Million SEK | -42.08% |
| 2015 Q1 | 13.89 Million SEK | 13.12% |
| 2015 Q4 | 19.92 Million SEK | 137.92% |
| 2015 FY | 56.64 Million SEK | 20.77% |
| 2014 Q1 | 10.18 Million SEK | 138.84% |
| 2014 FY | 46.9 Million SEK | 138.98% |
| 2014 Q3 | 12.15 Million SEK | -0.98% |
| 2014 Q4 | 12.28 Million SEK | 1.04% |
| 2014 Q2 | 12.27 Million SEK | 20.55% |
| 2013 Q3 | 4.53 Million SEK | -17.36% |
| 2013 Q4 | 4.26 Million SEK | -5.93% |
| 2013 FY | 19.62 Million SEK | -42.04% |
| 2013 Q1 | 5.34 Million SEK | -13.68% |
| 2013 Q2 | 5.48 Million SEK | 2.64% |
| 2012 Q2 | 11.22 Million SEK | 131.72% |
| 2012 FY | 33.86 Million SEK | 59.51% |
| 2012 Q1 | 4.84 Million SEK | -28.44% |
| 2012 Q3 | 11.61 Million SEK | 3.48% |
| 2012 Q4 | 6.19 Million SEK | -46.68% |
| 2011 Q2 | 4.59 Million SEK | -31.2% |
| 2011 Q3 | 3.19 Million SEK | -30.32% |
| 2011 Q4 | 6.76 Million SEK | 111.5% |
| 2011 FY | 21.22 Million SEK | -16.92% |
| 2011 Q1 | 6.67 Million SEK | -23.74% |
| 2010 Q2 | 8.72 Million SEK | 62.91% |
| 2010 Q3 | 2.72 Million SEK | -68.76% |
| 2010 FY | 25.55 Million SEK | -67.34% |
| 2010 Q4 | 8.75 Million SEK | 221.1% |
| 2010 Q1 | 5.35 Million SEK | 0.0% |
| 2009 FY | 78.24 Million SEK | 29.17% |
| 2008 FY | 60.57 Million SEK | -43.24% |
| 2007 FY | 106.72 Million SEK | -12.35% |
| 2006 FY | 121.75 Million SEK | 5.32% |
| 2005 FY | 115.59 Million SEK | -5.85% |
| 2004 FY | 122.77 Million SEK | -10.03% |
| 2003 FY | 136.46 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AddLife AB (publ) | 2.77 Billion SEK | 98.888% |
| Biotage AB (publ) | 1.14 Billion SEK | 97.316% |
| Bonesupport Holding AB (publ) | 533.12 Million SEK | 94.215% |
| Doxa AB (publ) | 9.9 Million SEK | -211.525% |
| Elekta AB (publ) | 6.77 Billion SEK | 99.545% |
| iZafe Group AB (publ) | 293 Thousand SEK | -10425.939% |
| Ortivus AB (publ) | 30.84 Million SEK | 0.0% |
| Q-linea AB (publ) | 995 Thousand SEK | -2999.598% |
| S2Medical AB (publ) | 5.03 Million SEK | -512.289% |
| Synsam AB (publ) | 617 Million SEK | 95.001% |